West Pharmaceutical Services (WST) Inventory (2009 - 2026)

West Pharmaceutical Services has disclosed Inventory across 18 years of filings, most recently posting $447.4 million for Q2 2026.

• In Q2 2026, Inventory rose 6.25% year-over-year to $447.4 million; the TTM figure through Jun 2026 stood at $447.4 million (up 6.25% YoY), while the FY2025 annual figure was $443.9 million, up 17.75% from the prior year.
• Inventory came in at $447.4 million for Q2 2026 at West Pharmaceutical Services, down from $452.6 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $452.6 million in Q1 2026 to a low of $377.0 million in Q4 2024.
• Average Inventory over 5 years is $424.3 million, with a median of $425.5 million recorded in 2024.
• Year-over-year, Inventory soared 34.27% in 2022 and retreated 13.27% in 2024.
• Over 5 years, Inventory stood at $414.8 million in 2022, then climbed by 4.8% to $434.7 million in 2023, then fell by 13.27% to $377.0 million in 2024, then rose by 17.75% to $443.9 million in 2025, then rose by 0.79% to $447.4 million in 2026.
• Per Business Quant data, the three most recent Inventory figures were $447.4 million in Q2 2026, $452.6 million in Q1 2026, and $443.9 million in Q4 2025.